Background: There is a growing interest in the use of cannabis (and its extracts), as well as
CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is …

Cannabinoid hyperemesis syndrome (CHS) is a (probably) rare syndrome that occurs in
frequent and chronic cannabis users. It is characterised by cyclical vomiting and …

Simple Summary Symptom management is a key goal of palliative cancer care. There is
growing interest in the use of cannabis-based medicines or products for the management of …

Introduction: Between 2013 and 2019, Illinois limited cannabis access to certified patients
enrolled in the Illinois Medical Cannabis Program (IMCP). In 2016, the state instituted a fast …

A form of hyperemesis known as cannabis hyperemesis syndrome (CHS) has gained
attention as a potential cannabis safety concern. CHS was first described as cyclical …

Cannabinoid Hyperemesis Syndrome: What Do We Know? Page 1 1 Med Cannabis
Cannabinoids , DOI: 10.1159/000539182 Received: April 22, 2024 Accepted: April 28, 2024 …

Cannabis hyperemesis syndrome (CHS) is a condition characterized by recurrent episodes
of severe vomiting, abdominal pain, and intractable nausea in chronic cannabis users. With …

Cannabis legalization may increase the rates of emergency department presentations and
hospitalizations from Cannabinoid Hyperemesis Syndrome (CHS). This syndrome was first …

Gastroenterologische Symptome sind häufig in der pädiatrischen Palliativversorgung und
werden oft als sehr leidvoll erlebt. So tritt z. B. bei etwa 30–40% der Kinder und …

Mr. James Jones [pseudonym] is a young African American man with no past medical history
aside from multiple hospitalizations for Cannabis Hyperemesis Syndrome (CHS). He …